For example, NCOR2 is downregulated in multiple myeloma and its low expression is associated with the development of non-Hodgkin’s lymphoma and poor prognosis of lung adenocarcinoma (LUAD) patients14–17. This evidence concerns the gene NCOR2 and non-Hodgkin lymphoma.